Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
about
Acute lymphoblastic leukaemiaGenetic Heterogeneity and Clonal Evolution of Tumor Cells and their Impact on Precision Cancer MedicineMolecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemiaNew and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemiaTOX gene: a novel target for human cancer gene therapyTumour Cell HeterogeneityTissue Regeneration in the Chronically Inflamed Tumor Environment: Implications for Cell Fusion Driven Tumor Progression and Therapy Resistant Tumor Hybrid CellsThe influence of subclonal resistance mutations on targeted cancer therapyRecapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture ModelsStem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic LeukemiaDeciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicineAcute myeloid leukaemia: a paradigm for the clonal evolution of cancer?Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignanciesGenomic profiling of B-progenitor acute lymphoblastic leukemiaRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineTumour heterogeneity and the evolution of polyclonal drug resistanceKilling me softly--future challenges in apoptosis researchCurrent concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemiaClonal evolution in hematological malignancies and therapeutic implicationsIKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingChildhood acute lymphoblastic leukemia: Integrating genomics into therapyApplication of single-cell genomics in cancer: promise and challengesSecondary mutations as mediators of resistance to targeted therapy in leukemiaGenomic and epigenomic heterogeneity in chronic lymphocytic leukemiaGenetic aberrations in imatinib-resistant dermatofibrosarcoma protuberans revealed by whole genome sequencingThe cancer genomeClonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingTumour heterogeneity and cancer cell plasticityTHetA: inferring intra-tumor heterogeneity from high-throughput DNA sequencing dataFunctionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia.Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments.Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data.An NGS Workflow Blueprint for DNA Sequencing Data and Its Application in Individualized Molecular Oncology.Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesisMeasurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing
P2860
Q24602387-757E91FE-74A3-46C9-892F-A32427DF3046Q24604479-3EAC07D2-00B1-4126-9351-9D87BBD5BF80Q24657303-145CE49E-DD7E-4D05-B73A-0628442BB193Q26749177-25B5D66A-F902-4B74-ACA2-222BBC9FDD67Q26765220-47760B62-8A91-4696-9D64-AC5165421942Q26765895-81909E99-4652-49E0-B460-0CA688C85DF4Q26772032-D5437669-A6DC-4F1C-AA70-BD68747DC024Q26781693-1E395B45-DEE6-4B6C-8B3D-2A500B65AE3EQ26797285-951447A8-4B41-49CB-A8E7-BFF760E1D519Q26799954-FA30D0FE-E801-41EB-9569-C0C87F872C5EQ26825186-5E167D08-E018-4363-AF29-48A81A735696Q26828997-46E8B9B8-53EB-4979-8996-51D7243FD54BQ26829652-65B7F9B0-90BF-4703-8A40-84B91CA29528Q26829976-244F2C16-3B6E-42A4-9F4F-0E79ECF7322CQ26864460-66841F83-F086-403D-9B42-7909E3B54273Q26866803-F3FB4021-BF60-46F6-BFB2-B9BDF34E857FQ27025213-E4C00C80-86F8-4843-9A78-EA89F3A1E255Q27025242-B6BDDBC9-291A-4FD2-A170-EF890C3A557AQ27027655-C707ADAD-55E1-4CB0-BCB3-69981ABE0F0DQ27851563-F36FCA0D-090C-4C2B-8E8C-0FCDC2C7F971Q27851831-D231AB7D-0552-4D3C-8393-52E417F82C93Q27852067-8D017DDD-A451-4756-BD60-5AAB0D970A02Q27860948-7E6D6894-5B22-44D9-B810-15E1E3BA5B2AQ28080463-AF54EB03-AF97-49CA-8EAA-9EDF9D152242Q28085411-78147FF1-9C77-4967-AEC2-AABEE74C5DE6Q28087213-E6DB7042-CF69-47B1-A606-53AA51E001F9Q28087672-03D653F1-C99F-414E-881D-5BF0FE9D646DQ28534967-3FC9D32B-C0BC-45F6-913C-2A2E54F46583Q29547643-8D384D5A-1F5D-4BD0-A9DA-CE14D37AF865Q29614647-3A629C3B-8F2E-4F7A-ACAA-E8C10DB611E5Q29617990-33848712-0DD0-43F2-8FAF-4D78FC2F3733Q30657925-8224CA4A-D4E3-4098-9C74-0D42991D5082Q30827619-71930A2F-8519-426C-9F54-B5582D14128FQ30827633-5191E5F5-C20A-4FE7-B00F-E0A7A43A9BACQ30832305-BEFA9F5F-A1A0-4BCD-B7EE-B886E7F8ACCCQ30832617-41CAD8A5-6733-4BBB-B2B3-8315083DCBAEQ30858364-B4990A4A-8363-4A2B-802A-41E3DF16C065Q31077769-D078555F-7B17-46CA-BF6E-BAEA5D6F0B96Q33358743-F87D1ABA-95D2-40F2-8E96-0984BB482853Q33531727-1F937805-6C2A-48D4-B975-7A8386F98A1C
P2860
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
@en
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
@nl
type
label
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
@en
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
@nl
prefLabel
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
@en
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia
@en
P2093
Christopher B Miller
James R Downing
Letha A Phillips
Sheila A Shurtleff
Xiaoping Su
P2860
P304
P356
10.1126/SCIENCE.1164266
P407
P577
2008-11-01T00:00:00Z